Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06056375 · ClinicalTrials.gov registry record · Phase 1
Biological and Behavioral Outcomes of Community Nature Walks
A Phase 1 study of Stress, Psychological and Stress Reaction, sponsored by Charlotte Tate.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06056375: Recruiting Phase 1 study of Stress, Psychological and Stress Reaction, sponsored by Charlotte Tate.
NCT06056375 is a Phase 1 study of Stress, Psychological and Stress Reaction that is actively recruiting participants, run by Charlotte Tate. The registered enrollment target is 200 participants, above the 167-participant average among 43 other Stress, Psychological trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06056375, a Phase 1 study of Stress, Psychological and Stress Reaction, is actively recruiting participants, sponsored by Charlotte Tate.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will test the efficacy of our proposed intervention to reduce embodied stress in four racial/ethnic groups (Black, Latinx, Pilipinx, and Pacific Islander) as a preventative intervention for health disparities found in these communities. The intervention is comprised of two phases. The first consists of community nature walks in a pristine redwood forest for six months. This is followed by chosen nature activities with family and/or friends for three months. The investigators will test the ability of these activities in nature to reduce chronic stress that underpins many health disparities using validated biological, behavioral, and sociocultural measures. The use of these measures is in alignment with the National Institute of Minority Health and Health Disparities (NIMHD) Research Framework, and will increase understanding of individual, interpersonal, community, and social level factors that lead to, and that can eliminate health disparities.
Conditions Studied
Interventions
- BEHAVIORAL Reclaiming Nature Intervention
Study Locations (1)
California
- San Francisco State University - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2026-09-01 |
| Phase | Phase 1 |
What NCT06056375 shows while recruiting
NCT06056375 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 167-participant average among 43 other Stress, Psychological trials with a reported enrollment target (20% higher).
The record links to 3 conditions, with Stress, Psychological appearing as the primary indexed condition, and to 1 intervention - of which Reclaiming Nature Intervention is the first listed.
NCT06056375 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06056375 about?
NCT06056375 is a clinical study titled "Biological and Behavioral Outcomes of Community Nature Walks". The investigators will test the efficacy of our proposed intervention to reduce embodied stress in four racial/ethnic groups (Black, Latinx, Pilipinx, and Pacific Islander) as a preventative intervention for health disparities found in these communities. The intervention is comprised of two phases. ...
What is the current status of trial NCT06056375?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 200 participants. The study started on 2023-02-01. Estimated completion is 2026-09-01.
What conditions does trial NCT06056375 study?
This clinical trial studies the following conditions: Stress, Psychological, Stress Reaction, Telomere Shortening.
What interventions are being tested in trial NCT06056375?
The interventions under investigation include: Reclaiming Nature Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06056375?
This trial is sponsored by Charlotte Tate, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06056375 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress, Psychological
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06056375's enrollment target sits among peer trials
200 10th of 43 higher than 34 of 43 other Stress, Psychological trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress, Psychological trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
Better Lifestyle Counseling for African American Women During Pregnancy
RECRUITING · NA
-
Testing Adapted Self-Help Plus (SH+) for Stress and Well-Being in International Students at a U.S. University
RECRUITING · NA
-
Pilot Testing of a Structural Racism Intervention for Immigrant Latinx Families
RECRUITING · NA
-
MindWalk Intervention for Older South Asian Caregivers of People With Cognitive Disabilities (CD)
RECRUITING · NA
-
Foundational Programs to Combat Clinician Stress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI